Dominique Lossignol

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

Nancy U. Lin, Véronique Dièras, Devchand Paul et al. · Clinical Cancer Research · 2009 · 656 citations · Full text

Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain

Jeremy Johnson, Mary Burnell-Nugent, Dominique Lossignol et al. · Journal of Pain and Symptom Management · 2009 · 606 citations · Full text

Cbd Extract, Thc Extract, Cannabis Use +13

An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics

Jeremy Johnson, Dominique Lossignol, Mary Burnell-Nugent et al. · Journal of Pain and Symptom Management · 2012 · 228 citations

Oncology, Health Sciences, Open-label Extension Study +12

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.

Eva Tomiak, Martine Piccart, Joseph Kerger et al. · Journal of Clinical Oncology · 1994 · 132 citations

A little help from steroids in oncology

Dominique Lossignol · Journal of Translational Internal Medicine · 2016 · 77 citations · Full text

Pain Medicine, Neuropathic Pain, Anticancer Effect +19